We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kamada

News List

Kamada Signs Supply Agreement with Israeli Health Authorities contractpharma
October 23, 2020
The Israeli health authorities have signed a supply agreement for the investigational Covid-19 plasma-derived Immunoglobulin (IgG), to be supplied by Kamada Ltd., a biopharmaceutical company which is partnered with Kedrion Biopharma in the development...
Kamada and Kedrion to develop immunoglobulin product for Covid-19 pharmaceutical-technology
April 30, 2020
Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human plasma-derived polyclonal immunoglobulin (IgG) product for potential Covid-19 treatment.
Kamada, Takeda Discuss GLASSIA Manufacturing Transition contractpharma
August 09, 2019
In discussions to extend transition of Kamada’s Alpha-1 Antitrypsin Deficiency treatment to Takeda.
Kamada Receives Additional Shire Milestone contractpharma
June 13, 2017
Achieves sales milestone in GLASSIA supply and distribution agreement